Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 25,000 Shares

Posted by Brenda Bartman on May 13th, 2026

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) CEO Roger Jeffs sold 25,000 shares of Liquidia stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $41.50, for a total value of $1,037,500.00. Following the sale, the chief executive officer owned 1,298,095 shares of the company’s stock, valued at approximately $53,870,942.50. This represents a 1.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $42.09, for a total value of $1,052,250.00.
On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.10, for a total value of $1,002,500.00.
On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The stock was sold at an average price of $40.60, for a total value of $764,863.40.
On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total value of $1,003,500.00.
On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total value of $132,000.00.
On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total value of $1,256,387.28.
On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total value of $859,891.96.
On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total value of $1,003,000.00.

Liquidia Stock Up 6.5%

Shares of NASDAQ:LQDA opened at $56.60 on Wednesday. The stock’s 50-day moving average price is $38.17 and its two-hundred day moving average price is $35.29. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. Liquidia Corporation has a 12-month low of $11.85 and a 12-month high of $57.00. The firm has a market cap of $5.03 billion, a price-to-earnings ratio of 404.31 and a beta of 0.41.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 81.61% and a net margin of 7.74%.The firm had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. The firm’s revenue was up 4187.1% on a year-over-year basis. On average, research analysts forecast that Liquidia Corporation will post 2.14 EPS for the current year.

Trending Headlines about Liquidia

Here are the key news stories impacting Liquidia this week:

Positive Sentiment: Liquidia delivered a major Q1 beat on both earnings and revenue, reinforcing confidence in its commercial momentum and profitability. Liquidia Corporation Reports First Quarter 2026 Financial Results
Positive Sentiment: YUTREPIA sales continue to accelerate, with management targeting at least $1 billion in net revenue by 2027, which suggests a long runway for growth if launch momentum continues. Positive Sentiment
Positive Sentiment: Needham and BTIG both raised price targets and maintained bullish ratings, signaling Wall Street sees more upside after the earnings release. Liquidia (NASDAQ:LQDA) Price Target Raised to $70.00 at Needham & Company LLC
Neutral Sentiment: CEO Roger Jeffs sold 25,000 shares under a pre-arranged 10b5-1 plan; the transaction is small relative to his remaining stake, but it may still draw some investor attention. SEC filing
Negative Sentiment: One recent note argued that YUTREPIA’s launch upside may be getting closer to a ceiling, suggesting the market could eventually question how much more share growth is available. Liquidia: Yutrepia’s Launch Momentum Is Approaching A Ceiling (Rating Downgrade)

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Needham & Company LLC lifted their price objective on Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a research note on Monday. Oppenheimer boosted their price target on Liquidia from $16.00 to $19.00 and gave the stock an “underperform” rating in a research report on Thursday, March 12th. Wells Fargo & Company lifted their price objective on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a report on Tuesday. Wall Street Zen raised Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Three analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $49.33.

Get Our Latest Stock Report on LQDA

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. acquired a new stake in Liquidia in the fourth quarter valued at $25,000. NewEdge Advisors LLC bought a new stake in Liquidia during the second quarter valued at $25,000. Skandinaviska Enskilda Banken AB publ bought a new stake in Liquidia during the third quarter valued at $30,000. FNY Investment Advisers LLC bought a new stake in Liquidia during the third quarter valued at $34,000. Finally, Covestor Ltd boosted its position in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after acquiring an additional 359 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Featured Articles

Insider Buying and Selling by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.